Finding 541828 (2024-004)

-
Requirement
B
Questioned Costs
-
Year
2024
Accepted
2025-03-31

AI Summary

  • Core Issue: JHHS is using an expired indirect cost rate for charging costs to a federal award.
  • Impacted Requirements: Compliance with OMB Uniform Guidance requires timely submission of new indirect cost proposals to avoid using outdated rates.
  • Recommended Follow-Up: JHHS should implement control procedures to ensure only approved rates are used and expedite the approval of new rate proposals.

Finding Text

2024-004: Use of Expired Federally Negotiated Rate Grantor: Department of Health and Human Services, National Institute of Health (NIH)/ National Institute on Drug Abuse Cluster: Research & Development Award Name: Clinical Support Services for the Research Efforts of the Stroke Branch, Section on Stroke Diagnostics and Therapeutics, NINDS, NIH Award Number: 75N95019C00074 Assistance Listing Title: National Institute of Neurological Disorders & Stroke Direct Award Assistance Listing Number: 93.RD Award Year: September 28, 2019 – September 27, 2024 Passthrough Entity: None Criteria In accordance with Section 2(c) of OMB Uniform Guidance Appendix IV to Part 200—Indirect (F&A) Costs Identification and Assignment, and Rate Determination for Nonprofit Organizations, organizations that have previously established indirect cost rates must submit a new indirect cost proposal to the cognizant agency for indirect costs within six months after the close of each fiscal year. Condition JHHS had a federally negotiated indirect cost rate agreement for the period 7/1/2015- 6/30/2019, which had an approved rate of 39.5%. An extension of the rate was granted through 6/30/2021, but the new indirect cost rate proposal has not been accepted. In FY24, JHHS continued to charge indirect costs to the National Institute of Neurological Disorders & Stroke Direct Award using this rate, despite the fact that this rate had expired. Cause As a result of JHHS staff turnover, management failed to finalize the new federally negotiated indirect cost rate in a timely manner. Rate negotiations are currently in progress. Effect JHHS has charged $145,295 of indirect costs to this award, which has been approved for reimbursement by the granting agency, but is using an expired rate agreement. Questioned Costs There are no questioned costs associated with this finding. JHHS has continued to use the historically accepted rate during the ongoing negotiations. Recommendation JHHS should establish control procedures to ensure that the indirect cost rates used are related to approved and effective rate agreements. Management should also ensure submitted rate proposals are approved in a timely manner such that there is no lapse in rate agreements or a provisional rate is established during periods of rate negotiations. Management’s Views and Corrective Action Plan Refer to Management’s View’s and Corrective Action Plan at the end of the report.

Corrective Action Plan

Finding 2024-004: Use of Expired Federally Negotiated Rate Grantor: Department of Health and Human Services, National Institute of Health (NIH)/ National Institute on Drug Abuse Cluster: Research & Development Award Name: Clinical Support Services for the Research Efforts of the Stroke Branch, Section on Stroke Diagnostics and Therapeutics, NINDS, NIH Award Number: 75N95019C00074 Assistance Listing Title: National Institute of Neurological Disorders & Stroke Direct Award Assistance Listing Number: 93.RD Award Year: September 28, 2019 – September 27, 2024 Passthrough Entity: None Management agrees with the finding and recommendation. Management notes the approved negotiated indirect cost and fringe benefit rate has expired and management has submitted updated rate proposals to HHS. HHS has acknowledged receipt of proposals and notes the proposals are pending review. Management will continue to request status updates and respond timely to any requests from HHS. Management will improve control procedures to ensure that the indirect cost rates used are related to approved and effective rate agreements. Additionally, management will ensure submitted rate proposals are approved in a timely manner or a provisional rate is established during periods of rate negotiations. Management anticipates this finding will be remediated by June 30, 2025.

Categories

Cash Management

Other Findings in this Audit

Programs in Audit

ALN Program Name Expenditures
84.181 Special Education-Grants for Infants and Families $2.23M
93.817 Hospital Preparedness Program (hpp) Ebola Preparedness and Response Activities $1.04M
93.926 Healthy Start Initiative $1.03M
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $1.01M
93.RD National Institute of Neurological Disorders & Stroke Direct Award $513,131
93.493 Consolidated Appropriations Act $321,225
93.958 Block Grants for Community Mental Health Services $287,801
21.027 Covid-19 Coronavirus State and Local Fiscal Recovery Funds $250,000
93.865 Child Health and Human Development Extramural Research $193,807
93.994 Maternal and Child Health Services Block Grant to the States $121,735
93.839 Blood Diseases and Resources Research $114,275
93.310 Trans-Nih Research Support $104,069
93.395 Cancer Treatment Research $103,975
93.788 Opioid Str $71,989
93.969 Pphf Geriatric Education Centers $65,163
93.959 Block Grants for Prevention and Treatment of Substance Abuse $49,243
10.558 Child and Adult Care Food Program $45,056
93.889 National Bioterrorism Hospital Preparedness Program $32,629
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $30,000
93.110 Maternal and Child Health Federal Consolidated Programs $16,646
93.838 Lung Diseases Research $15,903
10.559 Summer Food Service Program for Children $7,371
93.226 Research on Healthcare Costs, Quality and Outcomes $4,444
93.855 Allergy and Infectious Diseases Research $4,000
93.837 Cardiovascular Diseases Research $225
93.461 Covid-19 Hrsa Claims Reimbursement for the Uninsured Program and the Covid-19 Coverage Assistance Fund $-434,379